The National Veterinary Care Ltd (ASX: NVL) share price could be one to watch today after it gave an update to the market. The company didn’t classify it as market sensitive, but I thought there were a few bits of up-to-date and interesting numbers. Management firstly reminded investors that it now owns 65 clinics which is 18% growth since the start of the financial year, it owns 55 in Australia and 10 in New Zealand, with a couple more acquisitions planned for the end of July. A new piece of information was the organic growth in GP clinics. It…
To keep reading, enter your email address or login below.
The National Veterinary Care Ltd (ASX: NVL) share price could be one to watch today after it gave an update to the market. The company didn’t classify it as market sensitive, but I thought there were a few bits of up-to-date and interesting numbers.
Management firstly reminded investors that it now owns 65 clinics which is 18% growth since the start of the financial year, it owns 55 in Australia and 10 in New Zealand, with a couple more acquisitions planned for the end of July.
A new piece of information was the organic growth in GP clinics. It reported that clinic organic revenue growth was 3.11% so far and was in line with the first half of FY18. GP client visitor numbers were steady over the months of January to April 2018 compared to last year. I think this compares favourably compared to Greencross Limited’s (ASX: GXL) recent standalone vet numbers.
The Wellness Program, which is a pet owner membership program, now has 18,237 members. This membership base is from 51 clinics and represents growth of 72% since 1 July 2017. On average, member average spend increases by more than 90% after joining the program. It has a current retention rate of 79%.
National Vet Care also said it now has 401 independent clinics using its management services procurement, this is 23% growth since the start of the year and it has a retention rate of 98%. It’s going to expand into New Zealand in the first quarter of FY19.
Management said that the company has implemented its new IT and infrastructure so that the business has scalability and efficiencies. National Vet Care also has worked with new suppliers to secure better purchasing terms for clinics, many of which are the best in the industry.
National Vet Care re-iterated that revenue growth is expected to be greater than 25% of FY17’s statutory revenue, the gross margin is expected to be in line with FY17 and the underlying earnings before interest, tax, depreciation and amortisation (EBITDA) margin will likely be between 16% to 17%.
The company also expects to pay a dividend with the annual result.
I thought this was a solid update from National Vet Care. The organic growth of clinics is a slow burner, but it’s achieving good growth in its membership program, the management division and of course through acquisitions.
I’d be happy to buy more shares of National Vet Care at the current price, considering how well the business is going. It’s trading at around 23x FY18’s estimated earnings.
Does the pet industry send you barking mad? These top stocks might be more to your investing preferences.
For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..
But knowing which blue chips to buy, and when, can be fraught with danger.
The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2018."
Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.
The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.
Click here to claim your free report.
Motley Fool contributor Tristan Harrison owns shares of Greencross Limited and NATVETCARE FPO. The Motley Fool Australia owns shares of and has recommended Greencross Limited. The Motley Fool Australia owns shares of NATVETCARE FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.